In a breakthrough that researchers call an ‘unmitigated clinical success’, an artificial titanium-made heart has helped a man ...

CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Collaboration Agreement with Abbott for Phase 3 TECH-LVAD Trial On March 4, 2025, Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) announced a ...

Australia's first implant of a BiVACOR Total Artificial Heart has been announced as an unmitigated clinical success, with the patient becoming the ...

The global IV therapy and vein access devices market is on a trajectory of significant growth, projected to expand from USD 28.7 billion in 2024 to an estimated USD 47.3 billion by 2034. With a ...

The two major players in the Greater New Orleans health care industry – Ochsner Health and LCMC Health – continue to increase ...

John A. McCoy Jr., Vice President at Abbott Laboratories, sold 562 shares for $77,651 at an average price of $138.17 per ...

Vivani Medical (VANI) announced that it intends to spin off Cortigent, a division that develops brain implant devices to help people recover ...

Vitestro today launched its Aletta autonomous robotic phlebotomy device (ARPD) that performs automated blood draws.

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Basis Medical recently announced that its Seclusion catheter for the treatment of superficial vein reflux has received FDA ...